Literature DB >> 22454101

Diverse immune evasion strategies by human cytomegalovirus.

Vanessa Noriega1, Veronika Redmann, Thomas Gardner, Domenico Tortorella.   

Abstract

Members of the Herpesviridae family have the capacity to undergo both lytic and latent infection to establish a lifelong relationship with their host. Following primary infection, human cytomegalovirus (HCMV) can persist as a subclinical, recurrent infection for the lifetime of an individual. This quiescent portion of its life cycle is termed latency and is associated with periodic bouts of reactivation during times of immunosuppression, inflammation, or stress. In order to exist indefinitely and establish infection, HCMV encodes a multitude of immune modulatory mechanisms devoted to escaping the host antiviral response. HCMV has become a paradigm for studies of viral immune evasion of antigen presentation by both major histocompatibility complex (MHC) class I and II molecules. By restricting the presentation of viral antigens during both productive and latent infection, HCMV limits elimination by the human immune system. This review will focus on understanding how the virus manipulates the pathways of antigen presentation in order to modulate the host response to infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454101     DOI: 10.1007/s12026-012-8304-8

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  142 in total

Review 1.  ER quality control in the biogenesis of MHC class I molecules.

Authors:  Daniel C Chapman; David B Williams
Journal:  Semin Cell Dev Biol       Date:  2010-01-05       Impact factor: 7.727

2.  Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element.

Authors:  J M Cherrington; E S Mocarski
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.

Authors:  T R Jones; E J Wiertz; L Sun; K N Fish; J A Nelson; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.

Authors:  Juliet V Spencer; Kristen M Lockridge; Peter A Barry; Gaofeng Lin; Monica Tsang; Mark E T Penfold; Thomas J Schall
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Authors:  Christina Jenkins; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Tegument proteins of human cytomegalovirus.

Authors:  Robert F Kalejta
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

Review 7.  Transfusion-associated cytomegalovirus infections.

Authors:  S P Adler
Journal:  Rev Infect Dis       Date:  1983 Nov-Dec

Review 8.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

9.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors.

Authors:  M Mendelson; S Monard; P Sissons; J Sinclair
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

View more
  60 in total

Review 1.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

Review 2.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

Review 3.  Herpesvirus-bacteria synergistic interaction in periodontitis.

Authors:  Casey Chen; Pinghui Feng; Jørgen Slots
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

4.  High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination.

Authors:  Steven Sijmons; Kim Thys; Mirabeau Mbong Ngwese; Ellen Van Damme; Jan Dvorak; Marnix Van Loock; Guangdi Li; Ruth Tachezy; Laurent Busson; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 5.  Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.

Authors:  Bodo Plachter
Journal:  Med Microbiol Immunol       Date:  2016-08-12       Impact factor: 3.402

Review 6.  Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.

Authors:  Thomas J Gardner; Domenico Tortorella
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

7.  A Prominent Role of the Human Cytomegalovirus UL8 Glycoprotein in Restraining Proinflammatory Cytokine Production by Myeloid Cells at Late Times during Infection.

Authors:  Natàlia Pérez-Carmona; Pablo Martínez-Vicente; Domènec Farré; Ildar Gabaev; Martin Messerle; Pablo Engel; Ana Angulo
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

8.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

Review 9.  Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.

Authors:  Niels A W Lemmermann; Annette Fink; Jürgen Podlech; Stefan Ebert; Vanessa Wilhelmi; Verena Böhm; Rafaela Holtappels; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

10.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.